Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China

ObjectiveThis study aimed to assess the efficacy of innovative Chemiluminescence Immunoassay (CLIA) in testing Cryptococcal Antigen (CrAg) across two medical centers, employing the FDA-approved CrAg Lateral Flow Assay (LFA) by IMMY as a reference standard.MethodsThe study encompassed patients diagno...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhuo-Yun Tang, Ping Xu, Zhong-Hao Wang, Ting-Ting Wang, Dan Zhou, Ke-Ping Ao, Hua-Feng Song, Xiao-Yun Yin, Dong-Dong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1451539/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850266114391539712
author Zhuo-Yun Tang
Ping Xu
Zhong-Hao Wang
Ting-Ting Wang
Dan Zhou
Ke-Ping Ao
Hua-Feng Song
Xiao-Yun Yin
Dong-Dong Li
author_facet Zhuo-Yun Tang
Ping Xu
Zhong-Hao Wang
Ting-Ting Wang
Dan Zhou
Ke-Ping Ao
Hua-Feng Song
Xiao-Yun Yin
Dong-Dong Li
author_sort Zhuo-Yun Tang
collection DOAJ
description ObjectiveThis study aimed to assess the efficacy of innovative Chemiluminescence Immunoassay (CLIA) in testing Cryptococcal Antigen (CrAg) across two medical centers, employing the FDA-approved CrAg Lateral Flow Assay (LFA) by IMMY as a reference standard.MethodsThe study encompassed patients diagnosed with cryptococcosis at West China Hospital of Sichuan University (HX) between July 2022 and May 2023, and Suzhou Fifth People’s Hospital (SZ) from September 2020 to September 2023. All specimens underwent simultaneous detection using the LFA (IMMY, Norman, USA) and CLIA (Chuanglan, Suzhou, China).ResultsA total of 628 patients were enrolled, revealing a remarkable 99.20% concordance between LFA and CLIA (623/628, 99.20%). The LFA exhibited a sensitivity of 96.83% (244/252) and specificity of 98.35% (179/182). Among the 42 patients with unaltered CrAg titers, the changes of Signal-to-Cut-Off ratio (ΔS/CO) results exhibited a noteworthy discrepancy, with 71.43% (30/42) demonstrating a decreasing trend in ΔS/CO of at least 10%.ConclusionsThe CLIA method demonstrated commendable specificity and sensitivity, exhibiting a high level of agreement with the FDA-approved LFA method. Additionally, CLIA demonstrated superior utility for treatment monitoring compared to LFA, offering continuous insight into the fluctuation of CrAg concentrations.
format Article
id doaj-art-80fe2109b2ea42569289ee85ea259eb9
institution OA Journals
issn 2235-2988
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-80fe2109b2ea42569289ee85ea259eb92025-08-20T01:54:15ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-11-011410.3389/fcimb.2024.14515391451539Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of ChinaZhuo-Yun Tang0Ping Xu1Zhong-Hao Wang2Ting-Ting Wang3Dan Zhou4Ke-Ping Ao5Hua-Feng Song6Xiao-Yun Yin7Dong-Dong Li8Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Clinical Laboratory, The Fifth People’s Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, Jiangsu, ChinaDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Clinical Laboratory, The Fifth People’s Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, Jiangsu, ChinaDepartment of Clinical Laboratory, The Fifth People’s Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, Jiangsu, ChinaDepartment of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaObjectiveThis study aimed to assess the efficacy of innovative Chemiluminescence Immunoassay (CLIA) in testing Cryptococcal Antigen (CrAg) across two medical centers, employing the FDA-approved CrAg Lateral Flow Assay (LFA) by IMMY as a reference standard.MethodsThe study encompassed patients diagnosed with cryptococcosis at West China Hospital of Sichuan University (HX) between July 2022 and May 2023, and Suzhou Fifth People’s Hospital (SZ) from September 2020 to September 2023. All specimens underwent simultaneous detection using the LFA (IMMY, Norman, USA) and CLIA (Chuanglan, Suzhou, China).ResultsA total of 628 patients were enrolled, revealing a remarkable 99.20% concordance between LFA and CLIA (623/628, 99.20%). The LFA exhibited a sensitivity of 96.83% (244/252) and specificity of 98.35% (179/182). Among the 42 patients with unaltered CrAg titers, the changes of Signal-to-Cut-Off ratio (ΔS/CO) results exhibited a noteworthy discrepancy, with 71.43% (30/42) demonstrating a decreasing trend in ΔS/CO of at least 10%.ConclusionsThe CLIA method demonstrated commendable specificity and sensitivity, exhibiting a high level of agreement with the FDA-approved LFA method. Additionally, CLIA demonstrated superior utility for treatment monitoring compared to LFA, offering continuous insight into the fluctuation of CrAg concentrations.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1451539/fullcryptococcal antigencryptococcosischemiluminescence assay (CLIA)lateral flow assay (LFA)diagnostic performancetreatment monitoring
spellingShingle Zhuo-Yun Tang
Ping Xu
Zhong-Hao Wang
Ting-Ting Wang
Dan Zhou
Ke-Ping Ao
Hua-Feng Song
Xiao-Yun Yin
Dong-Dong Li
Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
Frontiers in Cellular and Infection Microbiology
cryptococcal antigen
cryptococcosis
chemiluminescence assay (CLIA)
lateral flow assay (LFA)
diagnostic performance
treatment monitoring
title Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
title_full Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
title_fullStr Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
title_full_unstemmed Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
title_short Evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of China
title_sort evaluation of cryptococcal antigen testing using a novel chemiluminescence assay in two medical centers of china
topic cryptococcal antigen
cryptococcosis
chemiluminescence assay (CLIA)
lateral flow assay (LFA)
diagnostic performance
treatment monitoring
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1451539/full
work_keys_str_mv AT zhuoyuntang evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT pingxu evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT zhonghaowang evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT tingtingwang evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT danzhou evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT kepingao evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT huafengsong evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT xiaoyunyin evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina
AT dongdongli evaluationofcryptococcalantigentestingusinganovelchemiluminescenceassayintwomedicalcentersofchina